How PhD was paid
$808,431 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Phillip P. Chan, MD, PhDChief Executive Officer | $502,165 | $87,804 | $105,600 | $100,862 | $12,000 | $808,431 |
| Peter J. MarianiChief Financial Officer | $442,000 | $79,821 | $71,500 | $66,551 | — | $659,872 |
| Vincent J. Capponi, MSPresident and Chief Operating Officer | $460,040 | $83,079 | $89,100 | $82,153 | — | $714,372 |
| Efthymios N. Deliargyris, MDChief Medical Officer | $432,586 | $78,121 | $70,000 | $70,248 | $12,500 | $663,455 |
What changed and why
- $808K$808,431 CEO total compensation in 2025 declined from $899,695 in 2024.
- $106K$105,600 in restricted stock units and $100,862 in stock options were awarded to the CEO.
- $87,804$87,804 CEO bonus was earned and accrued, but payment was deferred pending sufficient liquidity.
- $679K$679,233 was the average 2025 Summary Compensation Table total for non-PEO named executives.
- 2025 equity awards vested over multiple years, with restricted stock units vesting on the first and second anniversaries.
- $12,000$12,000 annual car allowance continued for the CEO; the Chief Medical Officer also received $12,500 in other compensation.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.